Roivant Sciences Ltd.

Roivant Sciences Ltd.verified

ROIV

Price:

$10.8

Market Cap:

$7.98B

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.[Read more]

Industry

Biotechnology

IPO Date

2020-12-08

Stock Exchange

NASDAQ

Ticker

ROIV

The Current Ratio as of July 2024 (TTM) for Roivant Sciences Ltd. (ROIV) is 25.24

According to Roivant Sciences Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 25.24. This represents a change of 54.71% compared to the average of 16.31 of the last 4 quarters.

Roivant Sciences Ltd. (ROIV) Historical Current Ratio (quarterly & annually)

How has ROIV Current Ratio performed in the past?

The mean historical Current Ratio of Roivant Sciences Ltd. over the last ten years is 13.86. The current 25.24 Current Ratio has changed 18.11% with respect to the historical average. Over the past ten years (40 quarters), ROIV's Current Ratio was at its highest in in the December 2023 quarter at 27.79. The Current Ratio was at its lowest in in the June 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

13.86

Median

10.82

Minimum

5.61

Maximum

25.24

Roivant Sciences Ltd. (ROIV) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Roivant Sciences Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 329.34%

Maximum Annual Current Ratio = 25.24

Minimum Annual Increase = -58.54%

Minimum Annual Current Ratio = 5.61

Quarterly (TTM)
Annual
YearCurrent RatioChange
202425.24282.27%
20236.60-43.30%
202211.6416.57%
20219.99-58.54%
202024.09329.34%

Roivant Sciences Ltd. (ROIV) Average Current Ratio

How has ROIV Current Ratio performed in the past?

The current Current Ratio of Roivant Sciences Ltd. (ROIV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

14.49

5-year avg

15.51

10-year avg

13.86

Roivant Sciences Ltd. (ROIV) Current Ratio vs. Peers

How is ROIV’s Current Ratio compared to its peers?

Roivant Sciences Ltd.’s Current Ratio is less than Krystal Biotech, Inc. (0), greater than Prometheus Biosciences, Inc. (12.66), less than Akero Therapeutics, Inc. (37.56), less than Apellis Pharmaceuticals, Inc. (30.12), greater than Day One Biopharmaceuticals, Inc. (3.77), greater than Phathom Pharmaceuticals, Inc. (10.93), greater than Blueprint Medicines Corporation (7.83), greater than Lyra Therapeutics, Inc. (3.76), greater than Cullinan Oncology, Inc. (4.78), greater than Ascendis Pharma A/S (20.33), greater than BeiGene, Ltd. (0.83), greater than Pliant Therapeutics, Inc. (2.08), greater than Syndax Pharmaceuticals, Inc. (16.12), greater than Revolution Medicines, Inc. (8.93), greater than Viridian Therapeutics, Inc. (18.45), greater than Inozyme Pharma, Inc. (23.99), greater than null (14.05),

Build a custom stock screener for Roivant Sciences Ltd. (ROIV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Roivant Sciences Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Roivant Sciences Ltd. (ROIV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Roivant Sciences Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Roivant Sciences Ltd.'s Current Ratio?

How is the Current Ratio calculated for Roivant Sciences Ltd. (ROIV)?

What is the highest Current Ratio for Roivant Sciences Ltd. (ROIV)?

What is the 3-year average Current Ratio for Roivant Sciences Ltd. (ROIV)?

What is the 5-year average Current Ratio for Roivant Sciences Ltd. (ROIV)?

How does the current Current Ratio for Roivant Sciences Ltd. (ROIV) compare to its historical average?